BSE NSE
Your Result on : Company News
Marksans Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524404
ISIN Demat
INE750C01026
Book Value (Rs)
30.5295026
NSE Symbol
MARKSANS
Divident Yield %
0.31
Market Cap
(Rs In Cr.)
11,809
P/E (TTM)
62.8
EPS (TTM)
4.15
Face Value
(Rs)
1
Date Heading
30-May-25 Relonchem receives marketing authorization for Metformin Hydrochloride
30-May-25 Marksans Pharma gets regulatory nod for marketing type-2 diabetes medi
30-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Press Release
27-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Analysts/Institutional
26-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Analysts/Institutional
22-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Copy of Newspaper Publ
22-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Copy of Newspaper Publ
21-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Analysts/Institutional
20-May-25 Marksans Pharma consolidated net profit rises 15.66% in the March 2025
20-May-25 Board of Marksans Pharma recommends final dividend
20-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Investor Presentation
19-May-25 Relonchem receives marketing authorization for Sennosides 7.5 mg table
19-May-25 Marksans Pharma Ltd - Announcement under Regulation 30 (LODR)-Press Re
19-May-25 Marksans Pharma Ltd - Marksans Pharma Limited - Press Release
15-May-25 Relonchem receives marketing authorization for Gabapentin 50 mg/ml ora
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)